PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-11.25
Negative P/E while Healthcare median is -0.85. Seth Klarman would scrutinize path to profitability versus peers.
6.21
P/S near Healthcare median of 6.07. Charlie Munger would examine if similar pricing reflects similar economics.
0.41
P/B less than half the Healthcare median of 1.76. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
65.81
Positive FCF while Healthcare median shows negative FCF. Peter Lynch would examine cash flow generation advantage.
45.90
P/OCF of 45.90 versus zero operating cash flow in Healthcare. Walter Schloss would verify operational quality.
0.41
Fair value ratio less than half the Healthcare median of 1.77. Joel Greenblatt would investigate if this discount is justified.
-2.22%
Negative earnings while Healthcare median yield is -2.46%. Seth Klarman would investigate path to profitability.
1.52%
Positive FCF while Healthcare median shows negative FCF. Peter Lynch would examine cash generation advantage.